Your browser doesn't support javascript.
loading
Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss.
Liu, Xijuan; Simon, Jeremy M; Xie, Haibiao; Hu, Lianxin; Wang, Jun; Zurlo, Giada; Fan, Cheng; Ptacek, Travis S; Herring, Laura; Tan, Xianming; Li, Mingjie; Baldwin, Albert S; Kim, William Y; Wu, Tao; Kirschner, Marc W; Gong, Kan; Zhang, Qing.
Afiliação
  • Liu X; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Simon JM; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA; UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Xie H; Department of Urology, Peking University First Hospital, Beijing, China.
  • Hu L; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Wang J; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Zurlo G; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Fan C; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Ptacek TS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Herring L; Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA; UNC Proteomics Core Facility, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Tan X; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Li M; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Baldwin AS; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Kim WY; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
  • Wu T; Department of Systems Biology, Harvard Medical School, Boston, MA 02115.
  • Kirschner MW; Department of Systems Biology, Harvard Medical School, Boston, MA 02115.
  • Gong K; Department of Urology, Peking University First Hospital, Beijing, China.
  • Zhang Q; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, U
Mol Cell ; 77(6): 1294-1306.e5, 2020 03 19.
Article em En | MEDLINE | ID: mdl-32023483

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma de Células Renais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Fosfotransferases (Aceptor do Grupo Álcool) / Proteína Supressora de Tumor Von Hippel-Lindau / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: Mol Cell Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma de Células Renais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Fosfotransferases (Aceptor do Grupo Álcool) / Proteína Supressora de Tumor Von Hippel-Lindau / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals / Humans Idioma: En Revista: Mol Cell Ano de publicação: 2020 Tipo de documento: Article